357 related articles for article (PubMed ID: 28631531)
1. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
[TBL] [Abstract][Full Text] [Related]
3. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
4. Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis.
Valade S; Azoulay E; Galicier L; Boutboul D; Zafrani L; Stepanian A; Canet E; Lemiale V; Venot M; Veyradier A; Mariotte E
Medicine (Baltimore); 2015 Oct; 94(40):e1692. PubMed ID: 26448017
[TBL] [Abstract][Full Text] [Related]
5. Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study.
Scholz L; Posch F; Schulz E; Gornicec M; Wölfler A; Reisinger AC; Reinisch A; Eller P; Eisner F; Kreuzer P; Stradner M; Rosenkranz AR; Krammer F; Schilcher G; Krause R; Hatzl S
Crit Care Explor; 2024 Feb; 6(2):e1046. PubMed ID: 38511127
[TBL] [Abstract][Full Text] [Related]
6. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K
Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
[TBL] [Abstract][Full Text] [Related]
7. Anakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis.
Lee BJ; Cao Y; Vittayawacharin P; É'Leima G; Rezk S; Reid J; Brem EA; Ciurea SO; Kongtim P
Eur J Haematol; 2023 Sep; 111(3):477-484. PubMed ID: 37385631
[TBL] [Abstract][Full Text] [Related]
8. Treatment and mortality of hemophagocytic lymphohistiocytosis in critically ill children: A systematic review and meta-analysis.
Tan CJ; Ng ZQ; Bhattacharyya R; Sultana R; Lee JH
Pediatr Blood Cancer; 2023 Mar; 70(3):e30122. PubMed ID: 36579732
[TBL] [Abstract][Full Text] [Related]
9. Streptococcus pneumoniae-Related Hemophagocytic Lymphohistiocytosis Treated with IVIG and Steroids.
Dumancas CY; Reyes HAG; Cosico J; Savadkar A; Lah S
Am J Case Rep; 2018 Jan; 19():25-28. PubMed ID: 29307884
[TBL] [Abstract][Full Text] [Related]
10. Enterovirus-Associated HLH: Addition of Anakinra to IVIG and Corticosteroids.
Hardman SJ; Tukur G; Waruiru C
J Clin Immunol; 2019 May; 39(4):373-375. PubMed ID: 31104275
[No Abstract] [Full Text] [Related]
11. [Treatment of hemophagocytic lymphohistiocytosis in patients in the intensive care unit].
Eichenauer DA; La Rosée P
Inn Med (Heidelb); 2023 Oct; 64(10):955-960. PubMed ID: 37702780
[TBL] [Abstract][Full Text] [Related]
12. The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.
Bami S; Vagrecha A; Soberman D; Badawi M; Cannone D; Lipton JM; Cron RQ; Levy CF
Pediatr Blood Cancer; 2020 Nov; 67(11):e28581. PubMed ID: 32725881
[TBL] [Abstract][Full Text] [Related]
13. Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
Knaak C; Schuster FS; Spies C; Vorderwülbecke G; Nyvlt P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
Shock; 2020 Jun; 53(6):701-709. PubMed ID: 31626037
[TBL] [Abstract][Full Text] [Related]
14. Critical care management of patients with hemophagocytic lymphohistiocytosis.
Buyse S; Teixeira L; Galicier L; Mariotte E; Lemiale V; Seguin A; Bertheau P; Canet E; de Labarthe A; Darmon M; Rybojad M; Schlemmer B; Azoulay E
Intensive Care Med; 2010 Oct; 36(10):1695-1702. PubMed ID: 20532477
[TBL] [Abstract][Full Text] [Related]
15. [Hemophagocytic lymphohistiocytosis in critically ill patients].
Eichenauer DA; Lachmann G; La Rosée P
Med Klin Intensivmed Notfmed; 2021 Mar; 116(2):129-134. PubMed ID: 33580314
[TBL] [Abstract][Full Text] [Related]
16. Hemophagocytic Lymphohistiocytosis in Intensive Care Unit: A 71-Case Strobe-Compliant Retrospective Study.
Barba T; Maucort-Boulch D; Iwaz J; Bohé J; Ninet J; Hot A; Lega JC; Guérin C; Argaud L; Broussolle C; Jamilloux Y; Richard JC; Sève P
Medicine (Baltimore); 2015 Dec; 94(51):e2318. PubMed ID: 26705219
[TBL] [Abstract][Full Text] [Related]
17. Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children.
Charlesworth JEG; Wilson S; Qureshi A; Blanco E; Mitchell A; Segal S; Kelly D; Weitz J; O'Shea D; Bailey K; Kavirayani A
Pediatr Blood Cancer; 2021 Sep; 68(9):e29102. PubMed ID: 34114322
[TBL] [Abstract][Full Text] [Related]
18. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
[TBL] [Abstract][Full Text] [Related]
19. Patients with Hemophagocytic Lymphohistiocytosis Who Need Intensive Care Can Be Successfully Rescued by Timely Using Etoposide-Based HLH Regimens.
Lv K; Cheng X; Zhou Y; Yu M; Wang S; Shen H; Li F
Int J Gen Med; 2024; 17():431-446. PubMed ID: 38333019
[TBL] [Abstract][Full Text] [Related]
20. Acute circulatory failure in critically ill patients with hemophagocytic syndrome.
Frapard T; Darmon M; Fadllalah J; Mariotte E; Valade S
J Crit Care; 2022 Aug; 70():154064. PubMed ID: 35598526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
